Diane C. Young - Net Worth and Insider Trading
Diane C. Young Net Worth
The estimated net worth of Diane C. Young is at least $2 Million dollars as of 2024-05-31. Diane C. Young is the SVP, CHIEF MEDICAL OFFICER of Celldex Therapeutics Inc and owns about 47,115 shares of Celldex Therapeutics Inc (CLDX) stock worth over $2 Million. Diane C. Young is also the VP, Chief Medical Officer of Oncternal Therapeutics Inc and owns about 328 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $3,021. Details can be seen in Diane C. Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Diane C. Young has not made any transactions after 2022-08-17 and currently still holds the listed stock(s).
Transaction Summary of Diane C. Young
Diane C. Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Diane C. Young owns 2 companies in total, including Celldex Therapeutics Inc (CLDX) , and Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Diane C. Young’s form 4 insider trades.
Insider Ownership Summary of Diane C. Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2022-08-17 | SVP & Chief Medical Officer |
| ONCT | Oncternal Therapeutics Inc | 2018-07-16 | VP & Chief Medical Officer |
Diane C. Young Latest Holdings Summary
Diane C. Young currently owns a total of 2 stocks. Among these stocks, Diane C. Young owns 47,115 shares of Celldex Therapeutics Inc (CLDX) as of August 17, 2022, with a value of $2 Million and a weighting of 99.81%. Diane C. Young also owns 328 shares of Oncternal Therapeutics Inc (ONCT) as of July 16, 2018, with a value of $3,021 and a weighting of 0.19%.
Latest Holdings of Diane C. Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2022-08-17 | 47,115 | 33.30 | 1,568,930 |
| ONCT | Oncternal Therapeutics Inc | 2018-07-16 | 328 | 9.21 | 3,021 |
Holding Weightings of Diane C. Young
Diane C. Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Diane C. Young has made a total of 3 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Celldex Therapeutics Inc is the sale of 19,000 shares on August 17, 2022, which brought Diane C. Young around $708,700.
According to the SEC Form 4 filings, Diane C. Young has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 15 shares on July 16, 2018, which brought Diane C. Young around $30,120.
Insider Trading History of Diane C. Young
- 1
Diane C. Young Trading Performance
GuruFocus tracks the stock performance after each of Diane C. Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Diane C. Young is 37.18%. GuruFocus also compares Diane C. Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by Diane C. Young within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Diane C. Young's insider trading performs compared to the benchmark.
Performance of Diane C. Young
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.92 | | | | | |
| Relative Return to S&P 500(%) | 25.83 | | | | | |
Diane C. Young Ownership Network
Diane C. Young Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Diane C. Young is the SVP & Chief Medical Officer of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include Sen. VP & Ch Scientific Off. Tibor Keler , SVP of Corp. Affairs & Admin. Sarah Cavanaugh , and director & President and CEO Anthony S Marucci .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Diane C. Young made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 16,860 shares made by Tibor Keler ,
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,860 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,860 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Diane C. Young Mailing Address
Above is the net worth, insider trading, and ownership report for Diane C. Young. You might contact Diane C. Young via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
